169 related articles for article (PubMed ID: 17591043)
1. Prognostic factors and outcome of resected patients for gastrointestinal stromal tumors.
Chiappa A; Zbar AP; Biffi R; Bertani E; Pace U; Pruneri G; Della Vigna P; Grassi C; Valerio M; Poldi D; Andreoni B
Hepatogastroenterology; 2007; 54(75):693-6. PubMed ID: 17591043
[TBL] [Abstract][Full Text] [Related]
2. Surgical management and clinical outcome of gastrointestinal stromal tumor of the colon and rectum.
Chen CW; Wu CC; Hsiao CW; Fang FC; Lee TY; Che FC; Tsai WC; Jao SW
Z Gastroenterol; 2008 Aug; 46(8):760-5. PubMed ID: 18759198
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
4. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
6. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
7. An audit of surgical management of gastrointestinal stromal tumours (GIST).
Bucher P; Egger JF; Gervaz P; Ris F; Weintraub D; Villiger P; Buhler LH; Morel P
Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
[TBL] [Abstract][Full Text] [Related]
8. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
Hsu KH; Yang TM; Shan YS; Lin PW
Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
[TBL] [Abstract][Full Text] [Related]
9. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S
Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
[TBL] [Abstract][Full Text] [Related]
10. Primary and recurrent retroperitoneal sarcoma: factors affecting survival and long-term outcome.
Chiappa A; Zbar AP; Biffi R; Bellomi M; Orecchia R; Marsiglia H; Bertani E; De Braud F; Crotti C; Andreoni B
Hepatogastroenterology; 2004; 51(59):1304-9. PubMed ID: 15362739
[TBL] [Abstract][Full Text] [Related]
11. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).
Sym SJ; Ryu MH; Lee JL; Chang HM; Kim TW; Kim HC; Kim KH; Yook JH; Kim BS; Kang YK
J Surg Oncol; 2008 Jul; 98(1):27-33. PubMed ID: 18452195
[TBL] [Abstract][Full Text] [Related]
12. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
13. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.
Pawlik TM; Vauthey JN; Abdalla EK; Pollock RE; Ellis LM; Curley SA
Arch Surg; 2006 Jun; 141(6):537-43; discussion 543-4. PubMed ID: 16785353
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of gastric gastrointestinal stromal tumors: analysis of 92 operated patients.
Lai IR; Chen CN; Lin MT; Lee PH
Dig Surg; 2008; 25(3):208-12. PubMed ID: 18577866
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment for gastrointestinal stromal tumor].
Wan DS; Wu XJ; Ding PR; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Kong LH; Liang XM; Luo RZ
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(15):1037-40. PubMed ID: 18005584
[TBL] [Abstract][Full Text] [Related]
16. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors.
Kobayashi K; Gupta S; Trent JC; Vauthey JN; Krishnamurthy S; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; McRae SE; Hicks ME
Cancer; 2006 Dec; 107(12):2833-41. PubMed ID: 17096432
[TBL] [Abstract][Full Text] [Related]
17. Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.
Nunobe S; Sano T; Shimada K; Sakamoto Y; Kosuge T
Jpn J Clin Oncol; 2005 Jun; 35(6):338-41. PubMed ID: 15928191
[TBL] [Abstract][Full Text] [Related]
18. What is the prognostic significance of metastatic lymph nodes in GIST?
Valadão M; de Mello EL; Lourenço L; Vilhena B; Romano S; Castro Ldos S
Hepatogastroenterology; 2008; 55(82-83):471-4. PubMed ID: 18613390
[TBL] [Abstract][Full Text] [Related]
19. Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients.
Schurr P; Kohrs D; Reichelt U; Kaifi J; Vashist Y; Bachmann K; Bogoevski D; Yekebas E; Izbicki J
Dig Surg; 2009; 26(3):229-35. PubMed ID: 19468233
[TBL] [Abstract][Full Text] [Related]
20. Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management.
Yao KA; Talamonti MS; Langella RL; Schindler NM; Rao S; Small W; Joehl RJ
Surgery; 2000 Oct; 128(4):604-12. PubMed ID: 11015094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]